# Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis

> **NCT05885763** · PHASE1 · COMPLETED · sponsor: **Vifor Fresenius Medical Care Renal Pharma** · enrollment: 30 (actual)

## Conditions studied

- End Stage Renal Disease on Hemodialysis

## Interventions

- **DRUG:** Difelikefalin Injection

## Key facts

- **NCT ID:** NCT05885763
- **Lead sponsor:** Vifor Fresenius Medical Care Renal Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-26
- **Primary completion:** 2023-10-09
- **Final completion:** 2023-10-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05885763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05885763, "Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05885763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*